Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126250062 | 12625006 | 2 | F | 20160915 | 20160805 | 20160928 | EXP | TR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-121579 | RANBAXY | 47.00 | YR | M | Y | 0.00000 | 20160928 | OT | GB | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126250062 | 12625006 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | CYCLICAL | U | 84764 | |||||||||
| 126250062 | 12625006 | 2 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | CYCLICAL | U | 0 | |||||||||
| 126250062 | 12625006 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | HIGH DOSE | U | 0 | |||||||||
| 126250062 | 12625006 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | CYCLICAL | U | 0 | |||||||||
| 126250062 | 12625006 | 5 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | HIGH DOSE | U | 0 | |||||||||
| 126250062 | 12625006 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | CYCLICAL | U | 0 | |||||||||
| 126250062 | 12625006 | 7 | SS | Rituximub | RITUXIMAB | 1 | Unknown | CYCLICAL | U | 0 | |||||||||
| 126250062 | 12625006 | 8 | C | GRANULOCYTE COLONY STIMULATING FACTOR | GRANULOCYTE COLONY-STIMULATING FACTOR NOS | 1 | Unknown | UNK | U | 0 | |||||||||
| 126250062 | 12625006 | 9 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126250062 | 12625006 | 10 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126250062 | 12625006 | 11 | C | VALACICLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126250062 | 12625006 | 1 | Mantle cell lymphoma |
| 126250062 | 12625006 | 2 | Mantle cell lymphoma |
| 126250062 | 12625006 | 3 | Mantle cell lymphoma |
| 126250062 | 12625006 | 4 | Mantle cell lymphoma |
| 126250062 | 12625006 | 5 | Mantle cell lymphoma |
| 126250062 | 12625006 | 6 | Mantle cell lymphoma |
| 126250062 | 12625006 | 7 | Mantle cell lymphoma |
| 126250062 | 12625006 | 8 | Product used for unknown indication |
| 126250062 | 12625006 | 9 | Infection prophylaxis |
| 126250062 | 12625006 | 10 | Infection prophylaxis |
| 126250062 | 12625006 | 11 | Infection prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126250062 | 12625006 | OT |
| 126250062 | 12625006 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126250062 | 12625006 | H1N1 influenza | |
| 126250062 | 12625006 | Influenza | |
| 126250062 | 12625006 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |